{"SPADE_N_07245": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07245", "Peptide Name": "CF-TAT-substrate", "Source": "Protein derived", "Family": "", "Gene": "Not found", "Sequence": "YGRKKRRQRRREILSRXPAYRKIL", "Sequence Length": 24, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "5(6)-Carboxyfluorescein", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C131H229N51O29", "Mass": 350298, "PI": 12.51, "Net Charge": 10, "Hydrophobicity": -1.738, "Half Life": "Mammalian:2.8 hourYeast:10 minE.coli:2 min", "Literature": [{"Title": "Cell-penetrating bisubstrate-based protein kinase C inhibitors.", "Pubmed ID": "23621550", "Reference": "ACS Chem Biol. 2013 Jul 19;8(7)1479-87.", "Author": "van Wandelen LT, van Ameijde J, Ismail-Ali AF, van Ufford HC, Vijftigschild LA, Beekman JM, Martin NI, Ruijtenbeek R, Liskamp RM.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23621550"}], "Frequent Amino Acids": "RKI", "Absent Amino Acids": "CDFHMNOTUVW", "Basic Residues": 11, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 16, "Positive Residues": 11, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04906", "Similarity": 1.0, "Sequence": "YGRKKRRQRRR"}, {"SPADE_ID": "SPADE_N_07214", "Similarity": 1.0, "Sequence": "GCGGGYGRKKRRQRRR"}, {"SPADE_ID": "SPADE_N_07216", "Similarity": 1.0, "Sequence": "CGGGYGRKKRRQRRR"}]}}}